SCMP Business EN

US and China clash over fentanyl and tariffs at global drugs meeting

The United States and China traded barbs at a ⁠UN drugs meeting on ⁠Monday, with Washington accusing Beijing of ⁠failing to stop sales of precursor chemicals for fentanyl and China dismissing the allegation as false while calling the US irresponsible. The exchange, delivered in separate statements at the UN’s annual Commission on Narcotic Drugs meeting in Vienna, underscored tensions ‌between the two countries over illicit drugs and tariffs, with their leaders due to meet in China at the end of...

Mar 09, 2026 &03000909202631; 17:00 UTC www.scmp.com Trending 5/5

Read original on www.scmp.com ↗

↘

Negative for markets

Sentiment score: -65/100

Moderate impact Short-term (days)

WHAT THIS MEANS

US-China tensions escalated at UN drugs meeting over fentanyl precursor chemicals and tariffs, with mutual accusations undermining cooperation on illicit drug control. This geopolitical friction could impact trade relations and pharmaceutical supply chains, particularly affecting companies with cross-border operations.

AI CONFIDENCE

72% High

SENTIMENT GAUGE

NEWS POWER SCORE

AFFECTED ASSETS

↓

S&P 500

^GSPCIndex

Expected to decline

Escalating US-China tensions increase geopolitical risk and potential tariff escalation affecting US equities

⇅

Euro / US Dollar

EURUSDCurrency

High volatility expected

Trade tensions create uncertainty; safe-haven flows may support USD strength

⇅

Oil (WTI Crude)

CL=FCommodity

High volatility expected

Trade friction could impact global economic growth expectations and energy demand

↓

IT→.MI

IT→.MIStock

Expected to decline

European exporters exposed to US-China trade disputes face headwinds

PRICE HISTORY

Loading chart...

⚡ SUGGESTED ACTION

Consider reducing exposure to US equities and companies with significant China operations. Monitor tariff announcements closely; defensive sectors and safe-haven assets (bonds, gold) may outperform in near term.

KEY SIGNALS

Escalating US-China diplomatic tensionsPotential tariff escalation riskSupply chain disruption concernsGeopolitical risk premium increasingPharmaceutical precursor chemical trade restrictions

SECTORS INVOLVED

PharmaceuticalsInternational TradeChemical ManufacturingDefense & Aerospace

Analysis generated on Mar 10, 2026 at 01:02 UTC

Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by SCMP Business. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

US and China clash over fentanyl and tariffs at global drugs meeting

RELATED INTELLIGENCE